Personnel Information

写真a

KEN'ICHI Yoshioka


Job title

Visiting Lecturer
To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2015.04
    -
    2016.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Visiting Lecturer
  • 2016.05
    -
    2017.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Visiting Lecturer
  • 2018.05
    -
    2019.04
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Visiting Lecturer
  • 2022.05
    -
    2023.04
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Biomedical Sciences and Engineering， Division of Integrative Molecular Biomedicine， Department of NCC Cancer Science， Visiting Lecturer
  • 2023.05
    -
    2024.04
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Biomedical Sciences and Engineering， Division of Integrative Molecular Biomedicine， Department of NCC Cancer Science， Visiting Lecturer
  • 2024.05
    -
    2024.09
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Biomedical Sciences and Engineering， Division of Integrative Molecular Biomedicine， Department of NCC Cancer Science， Visiting Lecturer
  • 2024.10
    -
    Now
    Institute of Science Tokyo， Visiting Lecturer
  • 2024.10
    -
    Now
    Institute of Science Tokyo， -， Graduate Schools， Integrative Molecular Biomedicine， Department of NCC Cancer Science， Visiting Lecturer

▼display all

To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Ileuchi, H., Matsuno, Y., Kusumoto-Matsuo, R., Ueno, T., Kojima, S., Ikegami, M., Kitada, R., Okuma, H., Kojima, Y., Yonemori, K., Yatabe, Y., Takamochi, K., Suzuki, K., Yoshioka, K., Mano, H., Kohsaka, S.. GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway. Oncogene. 2024.08; 43 3037-3048. ( DOI )

  2. Kohsaka, S., Yagishita, S., Shirai, Y., Matsuno, Y., Ueno, T., Kojima, S., Ileuchi, H., Ikegami, M., Kitada, R., Yoshioka, K., Toshimitsu, K., Tabata, K., Yokoi, A., Doi, T., Yamamoto, N., Owa, T., Hamada, A., Mano, H.. An RBM39 inhibitor, E7820, induces synthetic lethality in cancer cells with homologous recombination repair deficiency npj Precision Oncology. 2024.05; 8 117. ( DOI )

  3. Manaka, Y., Kusumoto-Matsuo, R., Matsuno, Y., Asai, H., and Yoshioka, K.. Single Base Substitution Signatures 17a, 17b, and 40 Are Induced by γ-Ray Irradiation in Association with Increased ROS Levels. Heliyon. 2024.03; 9 e28044. ( DOI )

To the head of this page.▲